en
recoveriX in your country
MOTOR REHABILITATION FOR LONG COVID PATIENTS

recoveriX for Long Covid
Study Results

Promising Results for Long Covid

Long COVID refers to a range of symptoms that persist for weeks or months after the acute phase of a COVID-19 infection, including fatigue, cognitive difficulties, and respiratory problems. The results of the MS study showed that recoveriX improves fatigue in patients with Multiple Sclerosis, and therefore we invited Long COVID patients to undergo 25 treatment sessions. To objectively mark improvements, we performed the following tests:

  • 6-Minute Walk Test (6MWT): Measures the distance in meters a patient is able to walk at a comfortable speed within six minutes. Normal: 614 meters.
  • Modified Fatigue Impact Scale: Measures fatigue over the past 4 weeks. Normal: 0.
  • Montreal Cognitive Assessment: Screens attention, concentration, executive functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and orientation. Normal: 26-30.
  • Nine Hole Peg Test (9HPT): A standardized assessment used to measure manual dexterity by timing how quickly an individual can place nine pegs into a pegboard and then remove them one by one. Normal: 31 seconds.
  • Box and Block Test (BBT): Evaluates manual dexterity and gross motor skills by assessing how many wooden blocks a participant can transfer from one compartment to another within a set time frame. Commonly used in rehabilitation to track progress and tailor treatment plans for individuals with upper extremity impairments. Normal: 65 blocks.

The diagram shows the improvement in gait duration with the recoveriX treatment. We performed two pre-assessments to ensure that the patient did not have fluctuations. The patient could walk around 380 meters before recoveriX and improved to about 450 meters after the recoveriX treatment. It is also interesting how quickly the patient improved.


Fatigue was significantly reduced by the recoveriX treatment, the patient slept better, and cognitive functions improved.

The fine motoric skills of both hands improved during the recoveriX therapy.


Hand and arm functions improved because of the recoveriX therapy.

So far, we have treated 3 patients with Long COVID, and we are reporting on the first patient here. The clinical study is currently ongoing.

Also have a look at our before and after videos, where you can see the improvements, stroke, multiple sclerosis etc. patients, made with the help of recoveriX!